Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Lixte Biotechnology Holdings, Inc. LIXT
$0.64
-$0.01 (-1.55%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
9410726.00000000
-
week52high
2.70
-
week52low
0.43
-
Revenue
0
-
P/E TTM
-1
-
Beta
-0.30484400
-
EPS
-0.39000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:30
Описание компании
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| van der Baan Bastiaan Jeroen | A | 10000 | 10000 | 30 дек 2022 г. |
| Bernards Rene | A | 150000 | 15000 | 15 дек 2022 г. |
| Bernards Rene | A | 135000 | 10000 | 12 дек 2022 г. |
| FORMAN ERIC | A | 102083 | 2484 | 22 ноя 2022 г. |
| FORMAN ERIC | A | 99599 | 1457 | 21 ноя 2022 г. |
| Brown Regina | A | 6300 | 2600 | 21 ноя 2022 г. |
| Brown Regina | A | 3700 | 2400 | 21 ноя 2022 г. |
| FORMAN ERIC | A | 98142 | 6059 | 18 ноя 2022 г. |
| FORMAN ERIC | A | 92083 | 2500 | 18 ноя 2022 г. |
| FORMAN ERIC | A | 89583 | 7648 | 18 ноя 2022 г. |
Новостная лента
LIXTE Biotechnology Holdings to Present at Planet MicroCap Showcase: VIRTUAL 2022 Investor Conference
Accesswire
30 ноя 2022 г. в 08:05
Presentation to be Broadcast Wednesday December 7 at 3:30 p.m. EST/12:30 p.m.
Short Squeeze Stocks: RDBX, MDVL and 3 Others Experts Think Are Ready to Pop
InvestorPlace
09 мая 2022 г. в 12:18
Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel's top short squeeze candidates.
Trending Penny Stocks to Watch As the First Week of May Ends
PennyStocks
05 мая 2022 г. в 18:16
Are these trending penny stocks on your watchlist in May? The post Trending Penny Stocks to Watch As the First Week of May Ends appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Short Squeeze Stocks: HCDI, ZYME and 3 Others Experts Think Are Ready to Pop
InvestorPlace
02 мая 2022 г. в 11:22
Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.
5 Short Squeeze Candidates To Watch This Week: Aterian, Harbor Custom Development Remain At The Top, Veru Joins
Benzinga
02 мая 2022 г. в 10:45
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.